Episode Details

Back to Episodes

Bite Size: Why a Psychophysiologist Thinks We're Treating Depression Wrong | Dr Paul Taylor

Published 1 week, 3 days ago
Description

Most conversations about depression treatment start and end with medication. But what if that starting point is too narrow?


Paul Taylor challenges a widely accepted assumption in mental health care that antidepressants are the primary or most effective solution for depression.

What he argues is not simplistic and not anti-medication. It’s more uncomfortable than that: that for many people, medication alone may not be enough to meaningfully address the deeper drivers of depression.

That raises a harder question most people never get asked: if medication isn’t the full answer, what is?

This is a conversation that sits in the tension between science, treatment norms, and lived experience. And it may change how you think about the way depression is actually treated in practice.

You can find Dr Paul at his website: https://www.paultaylor.biz/
or at his LinkedIn: https://www.linkedin.com/in/paultaylor1971/
Buy a copy of Dr Paul's new book: https://www.paultaylor.biz/books


Use Code "PQPODCAST10" to get 10% off your Lumo Coffee order:https://lumocoffee.com/

Interested in sharing your story? Email Producer Shannon at support@performanceintelligence.com today with your story and contact details.

Learn more about Andrew and Performance Intelligence: https://performanceintelligence.com/
Find out more about Andrew's Keynotes : https://performanceintelligence.com/keynotes/

Follow Andrew May: https://www.instagram.com/andrewmay/

Watch the Performance Intelligence Podcast on Youtube: https://www.youtube.com/@performanceintelligencepodcast

If you enjoy the podcast, we would really appreciate you leaving a short review on Apple Podcasts, Spotify or Google Play. It takes less than 60 seconds and really helps us build our audience and continue to provide high quality guests.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us